Argus Investors Counsel’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-17,106
Closed -$1.42M 97
2022
Q4
$1.42M Buy
17,106
+262
+2% +$20.8K 1.14% 43
2022
Q3
$1.2M Buy
16,844
+276
+2% +$23.9K 1.06% 43
2022
Q2
$1.44M Buy
16,568
+344
+2% +$32.2K 1.06% 49
2022
Q1
$1.76M Buy
16,224
+1,732
+12% +$179K 1.12% 47
2021
Q4
$1.87M Buy
14,492
+1,368
+10% +$168K 1.13% 46
2021
Q3
$1.59M Buy
13,124
+888
+7% +$108K 1.04% 51
2021
Q2
$1.38M Buy
12,236
+388
+3% +$40.8K 0.56% 52
2021
Q1
$1.13M Sell
11,848
-1,332
-10% -$122K 0.46% 54
2020
Q4
$1.05M Buy
13,180
+244
+2% +$17.7K 0.46% 53
2020
Q3
$801K Buy
12,936
+948
+8% +$61.7K 0.33% 56
2020
Q2
$791K Buy
11,988
+2,020
+20% +$121K 0.38% 54
2020
Q1
$473K Buy
9,968
+272
+3% +$13.6K 0.28% 55
2019
Q4
$532K Buy
9,696
+648
+7% +$34K 0.24% 59
2019
Q3
$443K Sell
9,048
-264
-3% -$13.2K 0.21% 62
2019
Q2
$485K Sell
9,312
-116
-1% -$5.84K 0.23% 57
2019
Q1
$468K Sell
9,428
-176
-2% -$7.92K 0.22% 57
2018
Q4
$347K Buy
9,604
+1,264
+15% +$52.8K 0.18% 58
2018
Q3
$426K Buy
+8,340
New +$369K 0.18% 52

Other funds holding TECH

Argus Investors Counsel's TECH Position: Q1 2023 in Review

Argus Investors Counsel sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 17,106 shares — an estimated $1.42M sold.

Argus Investors Counsel first reported a position in TECH in Q3 2018 and held it in 18 quarters. The position peaked at $1.87M in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

  • Argus Investors Counsel reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
  • Argus Investors Counsel sold 17,106 Bio-Techne shares in Q1 2023, an estimated $1.42M.
  • Argus Investors Counsel first reported a position in Bio-Techne in Q3 2018 and held it in 18 quarters.
  • Argus Investors Counsel's Bio-Techne position peaked at $1.87M in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Argus Investors Counsel's 13F filing for Q1 2023, filed 20 Apr 2023.